caspofungin actavis 50 mg powder for concentrate for solution for infusion
accord healthcare ireland ltd. - caspofungin - pdr/conc/soln for infus - 50 milligram(s) - other antimycotics for systemic use; caspofungin
caspofungin actavis 70 mg powder for concentrate for solution for infusion
accord healthcare ireland ltd. - caspofungin - pdr/conc/soln for infus - 70 milligram(s) - other antimycotics for systemic use; caspofungin
caspofungin 50 mg powder for concentrate for solution for infusion
ethypharm - caspofungin - powder for concentrate for solution for infusion - 50.00 milligram(s) - other antimycotics for systemic use; caspofungin
caspofungin 70 mg powder for concentrate for solution for infusion
ethypharm - caspofungin - powder for concentrate for solution for infusion - 70.00 milligram(s) - other antimycotics for systemic use; caspofungin
caspofungin 50mg powder for concentrate for solution for infusion
pinewood laboratories ltd - caspofungin - powder for concentrate for solution for infusion - 50 milligram(s) - other antimycotics for systemic use; caspofungin
caspofungin 70mg powder for concentrate for solution for infusion
pinewood laboratories ltd - caspofungin - powder for concentrate for solution for infusion - 70 milligram(s) - other antimycotics for systemic use; caspofungin
cancidas 50 mg
merck sharp & dohme israel ltd - caspofungin as acetate - powder for concentrate for solution for infusion - caspofungin as acetate 50 mg/vial - caspofungin - caspofungin - cancidas is indicated in adults and pediatric patients (3 months and older) for:- empirical therapy for presumed fungal infections in febrile, neutropenic patients.- treatment of candidemia and the following candida infections: intra-abdominal abscesses, peritonitis and pleural space infections. cancidas has not been studied in endocarditis, ostemyelitis, and meningitis due to candida.- treatment of esophageal candidiasis.- treatment of invasive aspergillosis in patients who are refractory to or intolerant to other therapies (i.e. amphotericin b, lipid formulations of amphotericin b, and/or itraconazole). cancidas has not been studied as initial therapy for invasive aspergillosis.
cancidas 70 mg
merck sharp & dohme israel ltd - caspofungin as acetate - powder for concentrate for solution for infusion - caspofungin as acetate 70 mg/vial - caspofungin - caspofungin - cancidas is indicated in adults and pediatric patients (3 months and older) for:- empirical therapy for presumed fungal infections in febrile, neutropenic patients.- treatment of candidemia and the following candida infections: intra-abdominal abscesses, peritonitis and pleural space infections. cancidas has not been studied in endocarditis, ostemyelitis, and meningitis due to candida.- treatment of esophageal candidiasis.- treatment of invasive aspergillosis in patients who are refractory to or intolerant to other therapies (i.e. amphotericin b, lipid formulations of amphotericin b, and/or itraconazole). cancidas has not been studied as initial therapy for invasive aspergillosis.
cancidas powder for injection 50 mgvial
msd pharma (singapore) pte. ltd. - caspofungin acetate eqv caspofungin - injection, powder, for solution - 50 mg - caspofungin acetate eqv caspofungin 50 mg/vial
cancidas powder for injection 70 mgvial
msd pharma (singapore) pte. ltd. - caspofungin acetate eqv caspofungin - injection, powder, for solution - 70 mg/vial - caspofungin acetate eqv caspofungin 70 mg/vial